Johnson & Johnson

$127.58
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$3.54 (-2.70%) Today
-$0.15 (-0.12%) As of 7:11 PM EDT after-hours

Why Robinhood?

You can buy or sell JNJ and other stocks, options, ETFs, and crypto commission-free!

About JNJ

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. Read More The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Employees
135,100
Headquarters
New Brunswick, New Jersey
Founded
1887
Market Cap
337.10B
Price-Earnings Ratio
21.18
Dividend Yield
2.78
Average Volume
7.34M
High Today
$131.23
Low Today
$127.14
Open Price
$131.20
Volume
15.71M
52 Week High
$148.99
52 Week Low
$121.00

Collections

JNJ News

CNBCAug 22

Johnson & Johnson opioid trial judge expected to issue landmark verdict Monday

658
ReutersAug 21

Oklahoma judge to rule on Monday in opioid lawsuit against J&J

164
ReutersAug 19

Top CEOs say companies should put social responsibility above profit

177

JNJ Earnings

$1.72
$2.01
$2.29
$2.58
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Available Oct 15, Pre-Market

Popular Stocks

More JNJ News

BenzingaAug 8

Johnson & Johnson to Participate in Barclays Global Consumer Staples Conference

125
ReutersJul 31

Oklahoma makes final bid to hold J&J responsible for opioid epidemic

1,203
ReutersJul 29

J&J says FTC probing efforts to protect arthritis drug Remicade

950
BenzingaJul 28

Johnson & Johnson - KBL Merger Corp Acquires Cannabis-Focused Biotech Company

1,504
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.